# US 2016/0354521 A1 · Method for manufacturing hollow needle-shaped body, and hollow needle-shaped body

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354521 A1
- Document ID: US20160354521A1
- Status: Published application
- Kind: A1
- Application number: 15/241,677
- Filed: 2016-08-19
- Published: 2016-12-08
- Earliest claimed: 2014-02-24
- Assignees: Toppan Printing Co., Ltd.
- Applicants: Toppan Printing Co., Ltd.
- Inventors: Tomoya SUMIDA
- Web page: https://patentgrep.com/patent/US20160354521A1

## CPC

- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61M 37/0015: {by using microneedles}
- B81B 1/008: {Microtips}
- B81C 1/00111: {Tips, pillars, i.e. raised structures (microneedles A61M37/0015)}
- C08J 7/123: {Treatment by wave energy or particle radiation (C08J7/18 takes precedence)}
- A61M 2037/0023: {Drug applicators using microneedles}
- A61M 2037/003: {having a lumen}
- A61M 2037/0053: {Methods for producing microneedles}
- B81B 2201/055: Microneedles
- C08J 2367/04: Polyesters derived from hydroxy carboxylic acids, e.g. lactones (C08J2367/06 takes precedence)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- B81B: MICROSTRUCTURAL DEVICES OR SYSTEMS, e.g. MICROMECHANICAL DEVICES (piezoelectric, electrostrictive or magnetostrictive elements per se H10N30/00, H10N35/00)
- B81C: PROCESSES OR APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OR TREATMENT OF MICROSTRUCTURAL DEVICES OR SYSTEMS (making microcapsules or microballoons B01J13/02; processes or apparatus specially adapted for the manufacture or treatment of piezoelectric, electrostrictive or magnetostrictive elements per se H10N30/01)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)

## Abstract

A method for manufacturing a hollow needle-shaped body includes producing a needle-shaped body having a substrate and a projection on a first surface of the substrate, and applying a laser beam to a second surface of the substrate opposite to the first surface such that a through hole that penetrates through the substrate and the projection is formed. The substrate and the projection are comprised of crystallized polyglycolic acid.

## Claims

### Claim 1

A method for manufacturing a hollow needle-shaped body, comprising:
producing a needle-shaped body having a substrate and a projection on a first surface of the substrate; and
applying a laser beam to a second surface of the substrate opposite to the first surface such that a through hole that penetrates through the substrate and the projection is formed,
wherein the substrate and the projection comprise crystallized polygiycolic acid.

### Claim 2 (depends on 1)

The method of claim 1, wherein the laser beam is an excimer laser beam.

### Claim 3 (depends on 1)

The method of claim 1, wherein the needle-shaped body is produced such that a height from the first surface to an apex of the projection is in a range of from 0.5 mm to 2.0 mm.

### Claim 4 (depends on 2)

The method of claim 2, wherein the needle-shaped body is produced such that a height from the first surface to an apex of the projection is in a range of from 0.5 mm to 2.0 mm.

### Claim 5 (depends on 3)

The method of claim 3, wherein the needle-shaped body is produced such that the height divided by a maximum diameter of the projection at a connection of the projection and the substrate is in a range of from 1.1 to 5.

### Claim 6 (depends on 4)

The method of claim 4, wherein the needle-shaped body is produced such that the height divided by a maximum diameter of the projection at a connection of the projection and the substrate is in a range of from 1.1 to 5.

### Claim 7 (depends on 1)

The method of claim 1, wherein the crystallized polyglycolic acid has a degree of crystallization of 40% or more.

### Claim 8 (depends on 2)

The method of claim 2, wherein the crystallized polyglycolic acid has a degree of crystallization of 40% or more.

### Claim 9 (depends on 3)

The method of claim 3, wherein the crystallized polyglycolic acid has a degree of crystallization of 40% or more.

### Claim 10 (depends on 4)

The method of claim 4, wherein the crystallized polyglycolic acid has a degree of crystallization of 40% or more.

### Claim 11

A hollow needle-shaped body, comprising:
a substrate; and
a projection formed on a surface of the substrate,
wherein the substrate and the projection have a through hole penetrating through the substrate and the projection and comprise crystallized polyglycolic acid.

### Claim 12 (depends on 11)

The hollow needle-shaped body of claim 11, wherein a height from the surface of the substrate to an apex of the projection is in a range of from 0.5 mm to 2.0 mm.

### Claim 13 (depends on 12)

The hollow needle-shaped body of claim 12, wherein the height divided by a maximum diameter of the projection at a connection of the projection and the substrate is in a range of from 1.1 to 5.

### Claim 14 (depends on 11)

The hollow needle-shaped body of claim 11, wherein the crystallized polyglycolic acid has a degree of crystallization of 40% % or more.

### Claim 15 (depends on 12)

The hollow needle-shaped body of claim 12, wherein the crystallized polyglycolic acid has a degree of crystallization of 40% or more.

### Claim 16 (depends on 13)

The hollow needle-shaped body of claim 13, wherein the crystallized polyglycolic acid has a degree of crystallization of 40% or more.

### Claim 17 (depends on 14)

The hollow needle-shaped body of claim 14, wherein the degree of crystallization of not more than 90%.

### Claim 18 (depends on 15)

The hollow needle-shaped body of claim 15, wherein the degree of crystallization of not more than 90%.

### Claim 19 (depends on 16)

The hollow needle-shaped body of claim 16, wherein the degree of crystallization of not more than 90%.
